ReviewParasite immunology2026
Immune Modulation by Plasmodium yoelii: Insights From Lethal and Non-Lethal Strains.
Review in Parasite immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Immunity beyond borders: non-lethalFrontiers in immunology · 2026Article
- Immune Modulation by Plasmodium yoelii: Insights From Lethal and Non-Lethal Strains.Parasite immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Malaria pathogenesis is driven by intricate host-parasite interactions that determine immune balance and clinical outcome. The Plasmodium yoelii model, particularly its lethal (17XL) and non-lethal (17XNL) strains, provides a robust framework to investigate these dynamics. This review integrates recent findings demonstrating that 17XL infections trigger excessive pro-inflammatory cytokine release and immune exhaustion, while 17XNL infections sustain regulated Th1/Th2 responses enabling parasite control and survival. Emerging pathways involving MIF, TLR7 signalling, and immune checkpoints (PD-1, LAG-3) underscore the immunological divergence between strains. Evidence converges on a central concept: malaria severity reflects not parasite load but the timing and resolution of host immune responses. Future research using humanised models, single-cell profiling, and immunomodulatory interventions will deepen our understanding of immune regulation and guide novel therapeutic and vaccine strategies against malaria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.